EZSolution™ Baricitinib

A 10 mM (5 mg in 1.35 ml) of the JAK1 and JAK2 inhibitor Baricitinib (Cat. No. 2842) in anhydrous DMSO.

Alternate Name/Synonyms: INCB028050, LY-3009104, LY 3009104, 2-[1-Ethylsulfonyl-3-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)pyrazol-1-yl]azetidin-3-yl]acetonitrile, INCB 028050

Appearance: Liquid

Appearance:

Appearance: 1187594-09-7

Appearance: Yes

Peptide sequence: N/A

Salt Form: No

Molecular Formula: C₁₆H₁₇N₇O₂S

Molecular Weight: 371.42

Cell-Permeable?: True

Purity: ≥98% by HPLC

Solubilities:

Handling: Do not take internally. Wear gloves and mask when handling the product! Avoid contact by all modes of exposure.

Country of Origin: USA

Tag Line: A potent and selective JAK1 and JAK2 inhibitor

MDL Number:

PubChem CID: 44205240

SMILES: CCS(=O)(=O)N1CC(C1)(CC#N)N2C=C(C=N2)C3=C4C=CNC4=NC=N3

InChi: InChI=1S/C16H17N7O2S/c1-2-26(24,25)22-9-16(10-22,4-5-17)23-8-12(7-21-23)14-13-3-6-18-15(13)20-11-19-14/h3,6-8,11H,2,4,9-10H2,1H3,(H,18,19,20)

InChi Key: XUZMWHLSFXCVMG-UHFFFAOYSA-N

Category: Biochemicals